Official Title
International Registry of Coronavirus Exposure in Pregnancy (IRCEP)
Brief Summary

The International Registry of Coronavirus Exposure in Pregnancy (IRCEP) is a prospective cohort study of pregnant and recently pregnant women who have been tested for SARS-CoV-2 (regardless of the result) or have been clinically diagnosed with COVID-19 by a health care professional. Data from the IRCEP will be used to evaluate the impact of COVID-19 on pregnancy and birth outcomes.

Detailed Description

The International Registry of Coronavirus Exposure in Pregnancy (IRCEP) will enroll women 18

years of age and older who are currently pregnant or have been pregnant women within the last

6 months, and who have been tested for SARS-CoV-2 (regardless of the result) or have been

clinically diagnosed with COVID-19 by a health care professional. As this is an international

registry, women from all countries are welcome to participate.



Women will enroll and provide information to the IRCEP via website and mobile app. After

signing the electronic informed consent document, registrants will answer questions on the

following modules: Demographics, Reproductive History, Height and Weight, Habits, Health

Conditions, Medications, Current Pregnancy, COVID-19 Infection Test, and COVID-19 Infection

Symptoms. Monthly follow-up modules will continue until the pregnancy outcome. In case of a

live birth, the Registry participant will continue with the Post-Partum Outcomes module until

the newborn is 90 days of age. Medical records from the mother and neonate will also be

requested.

Recruiting
COVID-19

Other: Tested for SARS-CoV-2 (regardless of the result)
This is an observational study with no intervention
Post-partum women
Pregnant Women

Other: Clinical diagnosis of COVID-19 by a health care professional
This is an observational study with no intervention
Post-partum women
Pregnant Women

Eligibility Criteria

Inclusion Criteria: - Pregnant women or women who have been pregnant within the last 6 months - Able to give electronic informed consent - Tested for SARS-CoV-2 (regardless of the result) or clinically diagnosed with COVID-19 by a health care professional

Exclusion Criteria: -

Eligibility Gender
Female
Eligibility Age
Minimum: 18 Years
Countries
United States
Locations

Pregistry
Los Angeles, California, 90045

Recruiting

Investigator: Diego Wyszynski, MD, MHS, PhD

Investigator: Sonia Hernandez-Diaz, MD, DrPH

Contacts

Diego Wyszynski, MD, MHS, PhD
(747) 200-5468
IRCEP@pregistry.com

Sonia Hernandez-Diaz, MD, DrPH
(747) 200-5468
IRCEP@pregistry.com

Diego Wyszynski, MD, MHS, PhD
Principal Investigator
CEO Pregistry

Pregistry
Harvard School of Public Health
NCT Number
MeSH Terms
Coronavirus Infections